Key facts
- Sevaro’s last known valuation is $70.0M (Mar 2023).
- It has raised $52.0M; the latest was Later Stage VC ($39.0M) in Sep 2025.
- Notable investors include Catalyst Investors, APA Venture Partners, Anderson & Stowe, Carson, Intermountain Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Sevaro
- ·The full record, as it builds
Funding rounds
No funding rounds for Sevaro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sevaro
Provider of telemedicine consultation service intended to deliver standard medical care to those who need it the most. The company's service is equipped with a mobile medical unit that enables a team of physicians to provide free medical screenings, education, and medications to those living with undiagnosed diseases in rural areas, enabling hospitals around the world to deliver timely and adequate care.
- Sector
- Healthcare
- HQ
- Franklin Park, NJ, United States
- Founded
- 2019
- Employees
- 100
- Website
- sevaro.com/
- Ownership
- Privately Held (backing)
Sevaro doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sevaro shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sevaro in its N-PORT filings yet. We sweep new filings monthly.